Direkt zum Inhalt
Merck

Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.

Toxicology letters (2014-03-04)
Yanfei Li, Dan Shen, Xiaomei Tang, Xin Li, Da Wo, Hongwei Yan, Rui Song, Jian Feng, Ping Li, Jie Zhang, Jue Li
ZUSAMMENFASSUNG

Cardiac hypertrophy is an independent risk factor for cardiovascular disease and its subsequent progression to heart failure represents a major cause of morbidity and mortality in the world. CGA is an important component of Chinese herbal medicine, acting as an antioxidant, scavenging free radicals and preventing inflammation. This study found that with the pre-treatment of chlorogenic acid in Iso-induced neonatal rat myocytes, the levels of the hypertrophic markers, ANP, BNP and β-MHC decreased. The nuclear translocation of NF-κB was blocked, whereas NF-κBIA, an inhibitor of NF-κB, was upregulated accordingly. And the level of the intracellular ROS was also reduced. These data reveal that chlorogenic acid may inhibit Iso-induced cardiac hypertrophy by attenuating NF-κB signaling pathway and suppressing ROS.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Chlorogensäure, ≥95% (titration)
Sigma-Aldrich
DL-Isoproterenol -hydrochlorid
Chlorogensäure, primary reference standard
Chlorogensäure, European Pharmacopoeia (EP) Reference Standard
Isoprenalin-sulfat, European Pharmacopoeia (EP) Reference Standard
Isoprenalin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard